510(k) Report

510(k) · Cleared

Cleared

Surshield Safety Winged Infusion Set

K031266510(k) TraditionalCleared May 30, 200339-day reviewClass II21 CFR 880.5440

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Terumo Corp. · FPA Set, Administration, Intravascular

Cleared on May 30, 2003 as substantially equivalent to K010103 (Terumo Medical Corp., 2001) after a 39-day review. Its family tree reaches back 1 generation to 2001. 7 later devices descend from it.

Decided
May 30, 2003
Review
39 days
Class
Class II
Product code
FPA
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K010103 (2001). 7 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2007: 2 descendants cleared2005: 1 descendant cleared2014: 3 descendants cleared2010: 1 descendant clearedK010103 · Surshield Winged Infusion Set · Terumo Medical Corp. · 2001200020052010201520202025
Descendants, by generation 1 generation forward: 2 descendants2 generations forward: 3 descendants3 generations forward: 2 descendants K010103 · Surshield Winged Infusion Set · Terumo Medical Corp. · 20010
  1. Root · 1 generation backK010103 Surshield Winged Infusion SetTerumo Medical Corp. · 2001
  2. This deviceK031266 Surshield Safety Winged Infusion SetTerumo Corp. · 2003
  3. Descendant · cites it directly · 6 of its ownK052887 Surflo Winged Infusion Set with Needle Protection (Surshield), Model…Terumo Europe N.V. · 2005
  4. Descendant · 2 generations on · 4 of its ownK070547 Surflo Winged Infusion Set with Filter and Needle Protection…Terumo Europe N.V. · 2007
  5. Descendant · cites it directly · 3 of its ownK072894 Surflo Winged Infusion Set with Needle Protection (Surshield)Terumo Europe N.V. · 2007
  6. Descendant · 2 generations on · 2 of its ownK100946 Intravscular Administration SetTerumo Europe N.V. · 2010
  7. Descendant · 3 generations on · 0 of its ownK140175 Intravascular Administration SetDelta Med Spa · 2014

Showing 5 of 7 descendants. See all descendants

Descendants cleared per year

2005: 12007: 22010: 12014: 3
2005high 3 (2014) · low 0 (2006)2026

Most influential descendants

Showing 5 of 7 · See all
  • K052887Surflo Winged Infusion Set with Needle Protection (Surshield), Model SV-S23BL35VSTerumo Europe N.V. · 2005 · cites it directly6descendants
  • K070547Surflo Winged Infusion Set with Filter and Needle Protection (Surshield)Terumo Europe N.V. · 2007 · 2 generations on4descendants
  • K072894Surflo Winged Infusion Set with Needle Protection (Surshield)Terumo Europe N.V. · 2007 · cites it directly3descendants
  • K100946Intravscular Administration SetTerumo Europe N.V. · 2010 · 2 generations on2descendants
  • K140175Intravascular Administration SetDelta Med Spa · 2014 · 3 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K010103Surshield Winged Infusion SetTerumo Medical Corp.2001—
0 (this device)K031266Surshield Safety Winged Infusion SetTerumo Corp.2003—
+1K052887Surflo Winged Infusion Set with Needle Protection (Surshield), Model…Terumo Europe N.V.2005—
+2K070547Surflo Winged Infusion Set with Filter and Needle Protection (Surshield)Terumo Europe N.V.2007—
+1K072894Surflo Winged Infusion Set with Needle Protection (Surshield)Terumo Europe N.V.2007—
+2K100946Intravscular Administration SetTerumo Europe N.V.2010—
+3K140175Intravascular Administration SetDelta Med Spa2014—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200510
200720
201010
201430
FIG. 1 — Lineage of K031266, 2001–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FPA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FPA device

  1. #1 K243841 Sparta Infusion Set for Insulinscore 13.4 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K010103Surshield Winged Infusion SetTerumo Medical Corp.2001—

Also cleared against K010103: 1 other device →

What descends from it? (7)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K052887Surflo Winged Infusion Set with Needle Protection (Surshield), Model SV-S23BL35VSTerumo Europe N.V.20056
K072894Surflo Winged Infusion Set with Needle Protection (Surshield)Terumo Europe N.V.20073

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K052887 (Terumo Europe N.V., 2005) has gone furthest, with 6 descendants of its own.
  • 1 other device also cites its predicate K010103.

How does its category compare?

All FPA devices

FPA Set, Administration, Intravascular: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · FPA

11in 2025

2007: 162008: 182009: 102010: 232011: 122012: 212013: 132014: 222015: 172016: 122017: 172018: 42019: 72020: 102021: 132022: 142023: 142024: 72025: 112026 (partial year): 5
2007high 23 (2010) · low 4 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FPA

225in 2025

2007: 75 days median2008: 89 days median2009: 166 days median2010: 120 days median2011: 87 days median2012: 96 days median2013: 90 days median2014: 89 days median2015: 123 days median2016: 195 days median2017: 240 days median2018: 177 days median2019: 161 days median2020: 327 days median2021: 186 days median2022: 213 days median2023: 340 days median2024: 244 days median2025: 225 days median2026 (partial year): 266 days median
2007high 340 (2023) · low 75 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FPA

98in 2025

2007: 172008: 152009: 1662010: 582011: 282012: 16, 4 Class I2013: 642014: 242015: 62016: 102017: 132018: 42019: 132020: 1072021: 12022: 9, 5 Class I2023: 12, 4 Class I2024: 13, 1 Class I2025: 98, 1 Class I2026 (partial year): 10, 2 Class I
2007high 166 (2009) · low 1 (2021)2026

Class I (17 since 2007) Class II/III not classified

Adverse event reports per year · FPA

34,506in 2025

2007: 1,4992008: 1,9412009: 2,5122010: 2,5372011: 4,4072012: 4,9302013: 4,6512014: 4,6952015: 6,6252016: 8,4702017: 6,4622018: 6,5742019: 11,2272020: 9,5632021: 10,4142022: 13,3932023: 10,9162024: 47,2102025: 34,506
2007high 47,210 (2024) · low 1,499 (2007)2025

MAUDE reports naming product code FPA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071675171,499
20081889151,941
2009101661662,512
201023120582,537
20111287284,407
2012219616 (4)4,930
20131390644,651
20142289244,695
20151712366,625
201612195108,470
201717240136,462
2018417746,574
201971611311,227
2020103271079,563
202113186110,414
2022142139 (5)13,393
20231434012 (4)10,916
2024724413 (1)47,210
20251122598 (1)34,506
2026526610 (2)—

What is it indicated for?

The Surshield Safety Winged Infusion Set is intended for intravenous administration of

fluids andor withdrawal of blood specimens using a syringe, luer adapter, or other

compatible/appropriate devices. The winged infusion set may be used for any patient

population with consideration given to patient size. Additionally, after withdrawal of the

needle from the patient's vein, the shield cover can be manually activated to cover the

needle to minimize risk of accidental needlestick.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K031266: Surshield Safety Winged Infusion Set.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K031266

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026